Stock Fundamentals

Company Information

Company Name
Lexicon Pharmaceuticals Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US5288723027
CIK: 0001062822
CUSIP: 528872104
Currency: USD
Full Time Employees: 81
Phone: 281 863 3000
Fiscal Year End: December
IPO Date: Apr 07, 2000
Description:

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. The company develops sotagliflozin, an orally-delivered small molecule drug for the treatment of hypertrophic cardiomyopathy, and ZYNQUISTA (sotagliflozin) for the treatment of type 1 diabetes. It also commercializes INPEFA (sotagliflozin), a once-daily oral tablet to reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visit in adults with heart failure or type 2 diabetes, CKD, and other cardiovascular risk factors. In addition, the company develops LX9851, an orally-delivered small molecule drug candidate for the treatment of obesity and associated cardiometabolic disorders, and pilavapadin (LX9211), an orally-delivered small molecule drug candidate for the treatment of neuropathic pain. It has strategic collaboration and license agreements with Viatris Inc. and Bristol-Myers Squibb Company. The company was incorporated in 1995 and is headquartered in The Woodlands, Texas.

Address:

2445 Technology Forest Boulevard, The Woodlands, TX, United States, 77381

Directors & Officers

Name Title Year Born
Dr. Michael S. Exton Ph.D. CEO & Director 1970
Mr. Scott M. Coiante Senior VP & CFO 1967
Mr. Brian T. Crum Senior VP, General Counsel & Secretary 1973
Ms. Wendy E. McDermott Senior Vice President of Human Resources 1971
Dr. Craig B. Granowitz M.D., Ph.D. Senior VP & Chief Medical Officer 1965
Ms. Kristen L. Alexander Vice President of Finance & Accounting 1968
Ms. Lisa M. DeFrancesco Senior Vice President of Investor Relations & Corporate Communications 1980
Dr. Suma Gopinathan M.S., Ph.D. Senior Vice President of Discovery 1973
Ms. Rachel Yap Martens Senior VP of Partnerships & Corporate Strategy 1984

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Feb 25, 2026 Raymond Debbane N/A Purchase 2.00K $1.49 $2.98K
Feb 23, 2026 Raymond Debbane N/A Purchase 100.00K $1.47 $147.00K
Feb 20, 2026 Raymond Debbane N/A Purchase 100.00K $1.48 $148.00K
Feb 19, 2026 Raymond Debbane N/A Purchase 50.00K $1.44 $72.00K
Feb 02, 2026 Invus Global Management, Llc N/A Purchase 1.54M $1.30 $2.00M

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Artal Group S A 154.73M Mar 31, 2026 34.83% $23.89 13.62%
FMR Inc 45.06M Mar 31, 2026 10.14% $0.00 19.09%
Siren, L.L.C. 44.30M Mar 31, 2026 9.97% $1.92 13.84%
Sessa Capital, L.P 17.91M Mar 31, 2026 4.03% $0.51 497.10%
Vanguard Group Inc 9.61M Dec 31, 2025 2.16% $0.00 0.89%
Vanguard Capital Management, LLC 9.52M Mar 31, 2026 2.14% $0.00 0.00%
Point72 Asset Management, L.P. 7.81M Mar 31, 2026 1.76% $0.02 2,651.38%
Millennium Management LLC 4.94M Mar 31, 2026 1.11% $0.00 2.55%
BlackRock Inc 3.32M Mar 31, 2026 0.75% $0.00 4.06%
Geode Capital Management, LLC 3.17M Mar 31, 2026 0.71% $0.00 26.76%
Jane Street Group LLC 2.67M Mar 31, 2026 0.60% $0.00 54.61%
UBS Group AG 2.48M Mar 31, 2026 0.56% $0.00 -17.43%
Marshall Wace Asset Management Ltd 2.38M Mar 31, 2026 0.54% $0.00 88.24%
Susquehanna International Group, LLP 2.12M Mar 31, 2026 0.48% $0.00 75.70%
Atlantic Trust Group, LLC 1.95M Dec 31, 2025 0.44% $0.00 -18.76%
CIBC Bancorp USA Inc. 1.80M Mar 31, 2026 0.41% $0.00 0.00%
Renaissance Technologies Corp 1.60M Mar 31, 2026 0.36% $0.00 507.97%
Vanguard Fiduciary Trust Co 1.33M Mar 31, 2026 0.30% $0.00 0.00%
Charles Schwab Investment Management Inc 1.31M Mar 31, 2026 0.30% $0.00 24.28%
Two Sigma Investments LLC 1.20M Mar 31, 2026 0.27% $0.00 88.23%

Shares Statistics

Shares Outstanding: 444.20M
Shares Float: 262.53M
% Insiders: 112.00%
% Institutions: 7,852.30%
Short % Float: 13.08%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Fidelity Growth Compy Commingled Pl S 22.43M 5.05% ▲ 3.55% Apr 30, 2026
2 Fidelity Growth Company Fund 15.49M 3.49% ▲ 4.44% Apr 30, 2026
3 Vanguard Total Stock Mkt Idx Inv 6.85M 1.54% ▲ 0.00% Apr 30, 2026
4 Fidelity Growth Company K6 4.61M 1.04% ▲ 3.82% Apr 30, 2026
5 Fidelity Series Growth Company 3.71M 0.84% ▲ 4.92% Apr 30, 2026
6 Vanguard Institutional Extnd Mkt Idx Tr 2.46M 0.55% ▲ 0.60% Apr 30, 2026
7 Fidelity Extended Market Index 1.11M 0.25% ▲ 3.22% Apr 30, 2026
8 Schwab US Small-Cap ETF™ 1.03M 0.23% ▲ 0.07% May 30, 2026
9 Blackrock Extended Mkt Fund CF 585.84K 0.13% ▲ 0.00% Apr 30, 2026
10 Vanguard Health Care ETF 544.60K 0.12% ▼ 0.37% Apr 30, 2026

Valuation Metrics

Enterprise Value: $873.17M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $986.12M
EBITDA: $-23.67M
PEG Ratio: $-0.14
Book Value: $0.48
Earnings/Share: $-0.07
Profit Margin: -37.46%
Operating Margin: -4.72%
ROA (TTM): -5.35%
ROE (TTM): -16.01%
Revenue (TTM): $69.64M
Revenue/Share (TTM): $0.19
Earnings Growth (YOY): -63.40%
Revenue Growth (YOY): 1,572.10%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 4.88x 0.52x 0.42x -5.87x -1.34x
2024-12-31 5.44x 0.70x 0.51x -12.65x -0.55x
2023-12-31 5.60x 1.08x 0.59x -13.11x -0.59x
2022-12-31 6.08x 0.43x 0.40x -36.24x -0.50x
2021-12-31 4.02x 0.01x 0.17x -108.59x -0.01x
2020-12-31 3.37x 0.08x 0.23x -3.29x -0.30x
2019-12-31 5.17x 2.10x 0.72x 6.84x 1.66x
2018-12-31 4.72x -0.16x 1.09x -4.97x -2.39x
2017-12-31 2.59x 4.48x 0.88x -19.57x -1.87x
2016-12-31 2.17x 0.44x 0.67x -20.89x -0.55x
2015-12-31 4.33x 0.28x 0.56x 0.22x 6.91x
2014-12-31 8.21x 0.34x 0.40x -44.55x -1.01x
2013-12-31 6.97x -0.01x 0.38x -51.94x -0.14x
2012-12-31 12.63x 0.05x 0.28x -51.28x -0.14x
2011-12-31 11.32x 0.16x 0.31x -45.13x -0.44x
2010-12-31 19.93x 0.12x 0.33x -35.20x -0.30x
2009-12-31 3.33x 0.41x 0.37x -30.33x -0.79x
2008-12-31 5.16x 0.16x 0.25x -35.87x -0.35x
2007-12-31 7.49x 0.12x 0.22x -27.05x -0.49x
2006-12-31 1.86x 0.38x 0.55x -16.98x -0.81x
2005-12-31 1.85x 0.43x 0.61x -11.01x -1.51x
2004-12-31 2.55x 0.31x 0.43x -17.84x -1.09x
2003-12-31 5.40x 0.34x 0.42x -192.59x -1.37x
2002-12-31 6.25x 0.02x 0.16x -8,984.71x -0.09x
2001-12-31 8.86x 0.00x 0.09x -138.98x 0.00x
2000-12-31 18.35x 0.01x 0.06x -84.06x -0.09x
1999-12-31 1.19x 1.15x 0.63x N/A -0.87x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about LXRX.US!